High Intensity Focused Ultrasound Effective, Safe Treatment for Seborrheic Keratosis
Researchers examined the safety and efficacy of using high intensity focused ultrasound to remove seborrheic keratosis.
Researchers examined the safety and efficacy of using high intensity focused ultrasound to remove seborrheic keratosis.
The relationship between mRNA COVID-19 vaccination and varicella zoster virus vaccination are assessed.
Dermatoses of the skin, and their relevance to the early detection of many systemic forms of cancer, are reviewed.
The efficacy and tolerability of a topical agent in the treatment of seborrheic keratosis is evaluated.
Topical diclofenac sodium 1% gel was compared with topical ibuprofen gel for the treatment of seborrheic keratosis lesions.
New data regarding the prevalence of skin disease in adults aged 70 and older, and the association of cutaneous
diseases and socioeconomic status, sex, and living status is provided.
Investigators aimed to identify the clinical, histologic, and molecular features of atrophic and hypertrophic photoaging.
Seborrheic keratoses (SKs) clearance with a topical solution of 40% hydrogen peroxide was highest among SKs on the face and lowest among SKs on the extremities.
A-101 40 is the first and only FDA-approved topical drug for raised seborrheic keratosis.
The investigators sought to evaluate the efficacy and safety of HP40 vs a vehicle for the treatment of seborrheic keratoses.